Literature DB >> 1494497

The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats.

M Diamant1, G Croiset, D de Wied.   

Abstract

When administered intracerebroventricularly (ICV) in rats, corticotropin-releasing factor (CRF) possesses arousing and anxiogenic properties, which may be found reflected in autonomic and behavioral activation. As these responses are dependent on dose and situation, ICV-injected CRF may affect behavioral responses to a defined stimulus in a different fashion than autonomic concomitants. Two experiments were conducted in order to test this hypothesis. In both experiments, rats were treated ICV with CRF or an artificial cerebrospinal fluid (aCSF) 5 min prior to a 15-min exposure to an electrified prod (shock-prod burying test, SPB test) in their home cages. In the first experiment, 0.3 ng CRF injected ICV in unhandled rats significantly reduced the prod-burying response to electric shock, in favor of immobility, whereas following 300 ng CRF ICV, the predominant behavioral response was grooming behavior. In contrast, habituated rats, implanted with telemetric devices to measure heart rate, core temperature, and gross activity in the second experiment, showed a significant increase of burying behavior after 0.3 ng CRF ICV, in comparison to vehicle-treated controls. However, simultaneous cardiac acceleration was of the same magnitude and duration in both groups. In addition, whereas similar rises in CT were observed in both groups during the SPB test, CRF-treated rats showed more marked rise in core temperature during the first 15 min of the posttest period. At the 24-h retention test, rats belonging to the CRF group showed burying behavior and HR responses, in onset, magnitude, and duration similar to day 1, whereas extinction of the burying response and tachycardia was found in controls. Changes in CT, although less marked, showed the same pattern as on day 1 in both groups. These results show a differential effect of central CRF on behavioral and autonomic activation induced by a well-defined stressful stimulus. The response to CRF seems to be not only situation related, but also dependent on the pretest experience of the animal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494497     DOI: 10.1016/0196-9781(92)90022-u

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Andrea Cippitelli; Lydia O Ayanwuyi; Estelle Barbier; Esi Domi; Jose M Lerma-Cabrera; Francisca Carvajal; Giulia Scuppa; Hongwu Li; Massimo Ubaldi; Markus Heilig; Marisa Roberto; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

2.  Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function.

Authors:  I Dijkstra; F J Tilders; G Aguilera; A Kiss; C Rabadan-Diehl; N Barden; S Karanth; F Holsboer; J M Reul
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

3.  Predator odor increases avoidance and glutamatergic synaptic transmission in the prelimbic cortex via corticotropin-releasing factor receptor 1 signaling.

Authors:  Lara S Hwa; Sofia Neira; Melanie M Pina; Dipanwita Pati; Rachel Calloway; Thomas L Kash
Journal:  Neuropsychopharmacology       Date:  2018-11-23       Impact factor: 7.853

4.  CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.

Authors:  Olivier George; Sandy Ghozland; Marc R Azar; Pietro Cottone; Eric P Zorrilla; Loren H Parsons; Laura E O'Dell; Heather N Richardson; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

5.  MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist.

Authors:  Heather N Richardson; Yu Zhao; Eva M Fekete; Cindy K Funk; Peter Wirsching; Kim D Janda; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2007-10-23       Impact factor: 3.533

6.  Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats.

Authors:  Owen Howard; Gregory V Carr; Tiffany E Hill; Rita J Valentino; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2008-05-31       Impact factor: 4.530

Review 7.  Models and mechanisms of anxiety: evidence from startle studies.

Authors:  Christian Grillon
Journal:  Psychopharmacology (Berl)       Date:  2007-12-06       Impact factor: 4.530

8.  Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test.

Authors:  Gabor Legradi; Mahasweta Das; Brian Giunta; Khemraj Hirani; E Alice Mitchell; David M Diamond
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.